Low-Dose Acetylsalicylic Acid Reduces T Cell Immune Activation: Potential Implications for HIV Prevention

IntroductionAcetylsalicylic acid (ASA) is a well-known and safe anti-inflammatory. At low-dose, it is prescribed to prevent secondary cardiovascular events in those with pre-existing conditions and to prevent preeclampsia. Little is known about how low-dose ASA affects the immune response. In this s...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Julie Lajoie, Monika M. Kowatsch, Lucy W. Mwangi, Geneviève Boily-Larouche, Julius Oyugi, Yufei Chen, Makobu Kimani, Emmanuel A. Ho, Joshua Kimani, Keith R. Fowke
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
HIV
Accès en ligne:https://doaj.org/article/f795b4bc44bb4994bf8fb9117f3c8b69
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!